Trials / Completed
CompletedNCT04289311
SMYLS: A Self-management Program for Youth Living With Sickle Cell Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 11 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether a web-based intervention using a mobile device is helpful for teens learning to care for and manage symptoms of sickle cell disease. The intervention lasts 12 weeks with a 3-month follow up period, and uses a smartphone or a tablet.
Detailed description
The purpose of the proposed study is to test the feasibility of SMYLS, an mHealth intervention designed to facilitate self-management behaviors in children and adolescents with sickle cell disease (SCD). Specifically, the investigators propose to test the feasibility of the intervention for improving transition from parent-managed to adolescent self-managed care. In addition, the investigators will evaluate the communication that takes place via the intervention between adolescents, their parents/caregivers, and healthcare providers. The investigators will work with the MUSC Pediatric Sickle Cell Clinic to identify and recruit 5 healthcare providers of children with SCD and 30 dyads of adolescents ages 11 - 17 SCD and their parent/caregiver (n = 60).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Voice Crisis Alert V2 | An mHealth intervention (app) with multiple components for self-management behavior development. Components include: electronic educational information, symptom monitoring and tracking, communication with a provider, health history entry and storage (including medication adherence). |
Timeline
- Start date
- 2020-07-13
- Primary completion
- 2021-05-11
- Completion
- 2021-12-17
- First posted
- 2020-02-28
- Last updated
- 2024-08-16
- Results posted
- 2024-08-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04289311. Inclusion in this directory is not an endorsement.